BIOGEN INC.

BIIB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $25.3B · 7,500 employees
181
SEC Filings
$210.73
Close 2026-09-09
7,500
Employees

Business Summary

Biogen Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for neurological and other serious diseases. Key marketed products include LEQEMBI (Alzheimer's disease), SKYCLARYS (Friedreich's ataxia), and TYSABRI. The company also develops biosimilars and has a pipeline including felzartamab, litifilimab, and salanersen, with collaborations with partners such as Eisai and Supernus.

Latest Stock Quote

BIIB 2026-09-09 $210.73 O:$210.5 H:$213.48 L:$209 Vol:0.7M VWAP:$211.3101
origin leaf: null

Next Earnings

expected 2026-10-28

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-062025-12-310000875045-26-000013EDGAR110K words
2025-02-122024-12-310000875045-25-000009EDGAR110K words
2024-02-142023-12-310000875045-24-000009EDGAR110K words
2023-02-152022-12-310000875045-23-000009EDGAR—
2022-02-032021-12-310000875045-22-000007EDGAR—
2021-02-032020-12-310000875045-21-000010EDGAR—
2020-02-062019-12-310000875045-20-000005EDGAR—
2019-02-062018-12-310000875045-19-000006EDGAR—
2018-02-012017-12-310000875045-18-000005EDGAR—
2017-02-022016-12-310000875045-17-000009EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-07-292026-06-300000875045-26-000075EDGAR58K words
2025-10-302025-09-300000875045-25-000049EDGAR60K words
2025-07-312025-06-300000875045-25-000033EDGAR57K words
2025-05-012025-03-310000875045-25-000018EDGAR49K words
2024-10-302024-09-300000875045-24-000032EDGAR57K words
2024-08-012024-06-300000875045-24-000025EDGAR52K words
2024-04-242024-03-310000875045-24-000016EDGAR45K words
2023-11-082023-09-300000875045-23-000038EDGAR66K words
2023-07-252023-06-300000875045-23-000030EDGAR60K words
2023-04-252023-03-310000875045-23-000016EDGAR—
2022-10-252022-09-300000875045-22-000031EDGAR—
2022-07-202022-06-300000875045-22-000025EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-290000875045-26-000073EDGAR12K words
2026-04-060000875045-26-000039EDGAR1K words
2026-03-310001193125-26-134889EDGAR6K words
2026-03-110000950157-26-000280EDGAR0K words
2026-02-110001193125-26-046803EDGAR1K words
2026-02-060000875045-26-000011EDGAR12K words
2026-01-140000875045-26-000003EDGAR1K words
2025-10-300000875045-25-000047EDGAR12K words
2025-10-140000875045-25-000040EDGAR1K words
2025-07-310000875045-25-000035EDGAR11K words

181 total filings indexed. 149 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

neurology rare-diseases biosimilars biopharmaceuticals

Company Identity

CIK0000875045
TickerBIIB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.biogen.com
Listed1991-09-17

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ad04a06d050d41ef85061af596ff38b5fa6bfd0a23a0e72aada578dedd26a013
parent: 9f18acdb58170aa2aab2d3aa673a5cea4514c54799c833891bfa4f2efb80e937
content hash: 70c298a233190b21a29aa67c74f17ca50c628330d1a0555555d527796f9ff52f
signed: 2026-09-28T19:00:30.420Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BIIB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BIIB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BIIB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.